Syntec Optics is a Rochester photonics manufacturer that just used a dilutive public raise to retire its bank line, print a profitable June quarter, and ask the market to treat a decades-old shop as a defense-and-space growth franchise. The operating company is real. The listing is a late-cycle de-SPAC. The investment debate is whether one recovered quarter after a biomedical shipping hold is the start of a mid-thirties gross-margin compounder, or whether the equity is capitalizing a narrative that still sits on thin earnings, three-customer concentration, and unfinished books. Chairman Al Kapoor remains the controlling owner. The June print is the first clean look at the recapitalized firm.
The raise changed the residual claim more than it changed the factory. Management sold stock through H.C. Wainwright near $7 a share and took in about $21 million net, then repaid the M&T revolving line and cancelled the facility in June. Cash jumped from a year-end sliver to about $14 million. That removed covenanted bank debt, but it also left a CEO stockholder loan on the balance sheet and registered a later resale path for more than thirty million already-outstanding shares. Second-quarter sales rose twenty six percent to just over $8 million, and the shop swung to a thin profit after a first-quarter hole. Gross margin recovered to twenty six percent from a mid-teens first quarter, still well short of the mid-thirties band management cites as historical and targeted. Communications, defense, and consumer all grew. Medical only normalized after the earlier hold.
The market is not paying for last year's almost-flat sales year. It is paying for NDAA onshoring, weekly-ship satellite waveguides, missile-guidance add-ons, and a claimed path back toward an eighteen-to-twenty percent earnings-before-interest band. Shares last changed hands near $7. That implies roughly $274 million of equity value after cash and remaining debt. That is a high-single-digit sales multiple on a shop that earned a few hundred thousand in one quarter and still lost money for the first half. The next tests are sequential delivery against the guided second-half range, a second consecutive quarter of mid-twenties-or-better gross margin, and whether the registered insider float stays quiet. If those three hold, the recap looks like working capital for a real ramp. If they slip, the multiple has a long way down.